Author

Harsh Amin

Observed name: Harsh V. Amin

OpenAlex ID: A5113060649

An all-oral regimen of decitabine-cedazuridine (DEC-C) plus venetoclax (VEN) in patients (pts) with newly diagnosed acute myeloid leukemia (AML) ineligible for intensive induction chemotherapy: Results from a phase 2 cohort of 101 pts.

2025 · Amer Methqal Zeidan, Elizabeth A. Griffiths, et al. · Journal of Clinical Oncology · 6

An Occluded Picture: a Case of a Young Patient Presenting With Acute Systolic Heart Failure

2025 · Harsh Amin, Abigail Bent, et al. · Journal of the American College of Cardiology

Reclassification of Ascertain (ASTX727-02) Myelodysplastic Syndrome (MDS) Patients: Outcomes Including Clinical Response, Overall Survival (OS), and Leukemia Free Survival (LFS) Based on IPSS-R and IPSS-M Scoring Systems

2023 · Guillermo Garcia-Manero, James McCloskey, et al. · Blood

Works count: 3

Citation count: 6

H-index: 1

I10-index: